Informazione tecnica HSE / 25 ° anno
/ Documenti disponibili:
45.553
/ Documenti scaricati: 34.422.289
/ Documenti scaricati: 34.422.289

This guidance is intended to describe the Food and Drug Administration's (FDA’s) current thinking regarding the scope and application of part 11 of Title of the Code of Federal Regulations; Electronic Records; Electronic Signatures (21 CFR Part 11).
This document provides guidance to persons who, in fulfillment of a requirement in a statute or another part of FDA's regulations to maintain records or submit information to FDA, have chosen to maintain the records or submit designated information electronically and, as a result, have become subject to part 11.
Part 11 applies to records in electronic form that are created, modified, maintained, archived, retrieved, or transmitted under any records requirements set forth in Agency regulations. Part 11 also applies to electronic records submitted to the Agency under the Federal Food, Drug, and Cosmetic Act (the Act) and the Public Health Service Act (the 29 PHS Act), even if such records are not specifically identified in Agency regulations (§ 11.1).
The underlying requirements set forth in the Act, PHS Act, and FDA regulations (other than part 31 11) are referred to in this guidance document as predicate rules.
FDA

ID 20876 | 08.12.2023 / Preview in allegato
_________
Update 08.12.2023
Circolare informativa ACCREDIA Prot. DC2023SPM124 DEL 05.12.2023 - All...

ID 2708 | 24.01.2022 / Documento di approfondimento ed esempio SISTEMA in allegato
Esempi di calcolo del Perfomance Lev...

Direttiva RED 2014/53/UE (già R&TTE 1999/5/CE)
Comunicazione della Commissione nell’ambito dell’applicazione della direttiva 2014/53/UE del Parlamento europeo ...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024